Facing an increasingly outraged public, the leading Big Pharma lobby group is hiking its annual dues by more than 50 percent as it prepares to defend its pharmaceutical company members against lawmakers and voters who want to rein in out-of-control drug prices. Politico reported Tuesday that “PhRMA hopes to improve its public image next year and stave off any legislative …
Jim Hightower – How Big Pharma Is Trying to Improve Its Image
Big news, people! Especially for those of you upset by the skyrocketing prices of the essential prescription medicines you take — including thousands of patients who were hit last year with a 5,000 percent price increase for one lifesaving drug! Determined to do something about those despised price hikes, drugmakers themselves have reached into their corporate toolbox for the two …
Doni Bloomfield – ‘Wolf of Pharma Street’ Holds Up Unwelcome Mirror to Industry
Martin Shkreli, the pharmaceutical CEO arrested on securities fraud charges this week, may have made drug price increases notorious in the U.S. But his strategy of finding an old drug, raising its price, and taking the profit is one that’s increasingly common among a new breed of drugmakers. Disdaining a business model dependent on expensive research and development, companies like …
Nick Barrickman – US pharmaceutical industry price-gouging and the case of Martin Shkreli
The decision by biotechnology firm Turing Pharmaceuticals to raise the cost of Pyrimethamine (or Daraprim), a drug used to treat toxoplasmosis, from $13.50 to more than $750 per pill, has aroused shock and outrage. Toxoplasmosis is a parasitic disease to which people with weakened immune systems from of diseases such as AIDS, as well as certain cancer patients, as well …